Alterity Therapeutics Ltd
F:PBN
Alterity Therapeutics Ltd
F:PBN
Price:
0.312
EUR
-1.89%
Market Closed
Market Cap:
€8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alterity Therapeutics Ltd
F:PBN
|
AU |
|
E
|
Evocati Capital Resources Inc
XTSX:EVOC.P
|
CA |
|
C
|
Carlo Gavazzi Holding AG
F:D9N
|
CH |
|
A
|
Arima Real Estate SOCIMI SA
F:3AZ
|
ES |
|
Scisparc Ltd
NASDAQ:SPRC
|
IL |
|
C
|
Capitan Mining Inc
XTSX:CAPT
|
CA |
|
Energiedienst Holding AG
OTC:ENGDF
|
CH |
|
A
|
Aspermont Ltd
XBER:00W
|
AU |
Wall St Price Targets
PBN Price Targets Summary
Alterity Therapeutics Ltd
Alterity Therapeutics Ltd
Wall Street analysts forecast PBN stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for PBN is 0.605 EUR with a low forecast of 0.599 EUR and a high forecast of 0.622 EUR.
Lowest Forecast
Price Target
0.599
EUR
92% Upside
Average Forecast
Price Target
0.605
EUR
94% Upside
Highest Forecast
Price Target
0.622
EUR
100% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBN's stock price target?
Price Target
0.605
EUR
0.605
EUR
According to Wall Street analysts, the average 1-year price target for PBN is 0.605 EUR with a low forecast of 0.599 EUR and a high forecast of 0.622 EUR.
What is the Revenue forecast for Alterity Therapeutics Ltd?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 147%.
